Bromide

Bromide

SCHEMBL6300825

Br.C[C@](Oc1ccc2c(c1CBr)CCCC2=O)(c1ccccc1)c1ncc[nH]1

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ADRB2 known ✓ P07550 1/20 0.32
ADRB1 known ✓ P08588 1/20 0.32
HTR1A known ✓ P08908 1/20 0.32
ADRB3 known ✓ P13945 1/20 0.32
SLC6A4 known ✓ P31645 1/20 0.32
SIGMAR1 known ✓ Q99720 1/20 0.32
LTB4R Q15722 3/20 0.35
LTB4R2 Q9NPC1 3/20 0.35
BRD4 O60885 3/20 0.32
TSHR P16473 1/20 0.32
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6700648 0.99 LTB4R (0.36) LTB4RLTB4R2BRD4ADRB2ADRB1
SCHEMBL6306125 0.89 LTB4R (0.47) LTB4RLTB4R2BRD4ADRB2ADRB1
SCHEMBL6299367 0.89 LTB4R (0.35) LTB4RLTB4R2BRD4ADRB2ADRB1
SCHEMBL6306132 0.89 LTB4R (0.47) LTB4RLTB4R2BRD4ADRB2ADRB1
SCHEMBL6300110 0.89 LTB4R (0.35) LTB4RLTB4R2BRD4ADRB2ADRB1
SCHEMBL6307052 0.88 BRD4 (0.37) LTB4RLTB4R2BRD4ADRB2ADRB1
SCHEMBL6299673 0.88 LTB4R (0.39) LTB4RLTB4R2BRD4ADRB2ADRB1
SCHEMBL6301029 0.88 LTB4R (0.35) LTB4RLTB4R2BRD4ADRB2ADRB1
SCHEMBL6300008 0.88 LTB4R (0.35) LTB4RLTB4R2BRD4ADRB2ADRB1
SCHEMBL6301786 0.88 LTB4R (0.35) LTB4RLTB4R2BRD4ADRB2ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6943183-B2 5-substituted tetralones as inhibitors of ras farnesyl transferase PFIZER INC (US) 2005-09-13 US disclosed
US-20040044057-A1 5- substituted tetralones as inhibitors of ras farnesyl trransferase WARNER-LAMBERT COMPANY 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044057-A1 5- substituted tetralones as inhibitors of ras farnesyl trransferase PTAR1, FNTA, GGPS1 ADRB2 2440/4885ADRB1 866/4885HTR1A 4741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.